Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

A review of image analysis and machine learning techniques for automated cervical cancer screening from pap-smear images.

William W, Ware A, Basaza-Ejiri AH, Obungoloch J.

Comput Methods Programs Biomed. 2018 Oct;164:15-22. doi: 10.1016/j.cmpb.2018.05.034. Epub 2018 Jun 26. Review.

PMID:
30195423
2.

Screening for Cervical Cancer.

Jin J.

JAMA. 2018 Aug 21;320(7):732. doi: 10.1001/jama.2018.11365. No abstract available. Erratum in: JAMA. 2018 Oct 2;320(13):1387.

PMID:
30140878
3.

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.

Ogilvie GS, van Niekerk D, Krajden M, Smith LW, Cook D, Gondara L, Ceballos K, Quinlan D, Lee M, Martin RE, Gentile L, Peacock S, Stuart GCE, Franco EL, Coldman AJ.

JAMA. 2018 Jul 3;320(1):43-52. doi: 10.1001/jama.2018.7464. Erratum in: JAMA. 2018 Dec 4;320(21):2273.

PMID:
29971397
4.

Accuracy of visual inspection performed by community health workers in cervical cancer screening.

Driscoll SD, Tappen RM, Newman D, Voege-Harvey K.

Int J Gynaecol Obstet. 2018 Sep;142(3):260-269. doi: 10.1002/ijgo.12535. Epub 2018 Jun 8. Review.

PMID:
29788542
5.

Factors Affecting Uptake of Cervical Cancer Screening Among African Women in Klang Valley, Malaysia

Nwabichie CC, Manaf RA, Ismail SB.

Asian Pac J Cancer Prev. 2018 Mar 27;19(3):825-831.

6.

A Literature Review of Cervical Cancer Screening in Transgender Men.

Gatos KC.

Nurs Womens Health. 2018 Feb;22(1):52-62. doi: 10.1016/j.nwh.2017.12.008. Review.

PMID:
29433700
7.

A nurse-led cervical screening clinic in primary care.

Young G.

Rev Infirm. 2018 Feb;67(238):47-48. doi: 10.1016/j.revinf.2017.11.028.

PMID:
29426562
8.

Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia.

Canfell K, Saville M, Caruana M, Gebski V, Darlington-Brown J, Brotherton J, Heley S, Castle PE.

BMJ Open. 2018 Jan 26;8(1):e016700. doi: 10.1136/bmjopen-2017-016700. Erratum in: BMJ Open. 2018 Mar 8;8(3):e016700corr1.

9.

Decisional balance and self-efficacy mediate the association among provider advice, health literacy and cervical cancer screening.

Kim K, Xue QL, Walton-Moss B, Nolan MT, Han HR.

Eur J Oncol Nurs. 2018 Feb;32:55-62. doi: 10.1016/j.ejon.2017.12.001. Epub 2017 Dec 11.

PMID:
29353633
10.

Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer: An Observational Cohort Study.

Castle PE, Kinney WK, Xue X, Cheung LC, Gage JC, Zhao FH, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Katki HA, Schiffman M.

Ann Intern Med. 2018 Jan 2;168(1):20-29. doi: 10.7326/M17-1609. Epub 2017 Nov 28.

PMID:
29181509
11.

Barriers and facilitators of cervical cancer screening practices among African immigrant women living in Brisbane, Australia.

Anaman-Torgbor JA, King J, Correa-Velez I.

Eur J Oncol Nurs. 2017 Dec;31:22-29. doi: 10.1016/j.ejon.2017.09.005. Epub 2017 Oct 13.

PMID:
29173823
12.

Integrative review of cervical cancer screening in Western Asian and Middle Eastern Arab countries.

Ali S, Skirton H, Clark MT, Donaldson C.

Nurs Health Sci. 2017 Dec;19(4):414-426. doi: 10.1111/nhs.12374. Epub 2017 Oct 23. Review.

PMID:
29058371
13.

Secondary prevention of cervical cancer.

Basu P, Mittal S, Bhadra Vale D, Chami Kharaji Y.

Best Pract Res Clin Obstet Gynaecol. 2018 Feb;47:73-85. doi: 10.1016/j.bpobgyn.2017.08.012. Epub 2017 Sep 6. Review.

PMID:
28988647
14.

Natural History of HPV Infection across the Lifespan: Role of Viral Latency.

Gravitt PE, Winer RL.

Viruses. 2017 Sep 21;9(10). pii: E267. doi: 10.3390/v9100267. Review.

15.

Role of HPV DNA testing in modern gynaecological practice.

Ronco G, Giorgi Rossi P.

Best Pract Res Clin Obstet Gynaecol. 2018 Feb;47:107-118. doi: 10.1016/j.bpobgyn.2017.08.002. Epub 2017 Aug 12. Review.

PMID:
28918099
16.

Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis.

Musa J, Achenbach CJ, O'Dwyer LC, Evans CT, McHugh M, Hou L, Simon MA, Murphy RL, Jordan N.

PLoS One. 2017 Sep 5;12(9):e0183924. doi: 10.1371/journal.pone.0183924. eCollection 2017. Review. Erratum in: PLoS One. 2017 Dec 29;12 (12 ):e0190661.

17.

Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women: Focused literature review.

Madzima TR, Vahabi M, Lofters A.

Can Fam Physician. 2017 Aug;63(8):597-601. Review.

18.

A qualitative study exploring factors associated with Pap test use among North Korean refugees.

Kim K, Kim S, Chung Y.

Health Care Women Int. 2017 Oct;38(10):1115-1129. doi: 10.1080/07399332.2017.1359605.

19.

Screening Women at High Risk for Cervical Cancer: Special Groups of Women Who Require More Frequent Screening.

Vegunta S, Files JA, Wasson MN.

Mayo Clin Proc. 2017 Aug;92(8):1272-1277. doi: 10.1016/j.mayocp.2017.06.007. Review.

PMID:
28778260
20.

The Bethesda System for Reporting Cervical Cytology: A Historical Perspective.

Nayar R, Wilbur DC.

Acta Cytol. 2017;61(4-5):359-372. doi: 10.1159/000477556. Epub 2017 Jul 11. Review.

Supplemental Content

Loading ...
Support Center